Viral Testing Market

It is the process of analyzing virus contamination by querying samples of body fluids, hemoglobin or socially infected areas, and analyzing under the guidance of an electronic oscilloscope.

Viral Testing Market contains market size and forecasts of Viral Testing in global, including the following market information:

Global Viral Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Viral Testing Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Viral Testing companies in 2021 (%)

The global Viral Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Direct Fluorescent Antibody (DFA) Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Viral Testing include Roche, Agilent Technologies, Thermo Fisher Scientific, QIAGEN International, Lonza, Wuxi Pharmatech (Cayman), Merck, Eurofins Scientific and General Electric, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Viral Testing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Viral Testing Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Viral Testing Market Segment Percentages, by Type, 2021 (%)

• Direct Fluorescent Antibody (DFA) Test
• Immunochromatographic Assay
• RT-PCR-Based Test
• Agglutination Assay
• Flow-Through Assay
• Solid-Phase Assay

Global Viral Testing Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Viral Testing Market Segment Percentages, by Application, 2021 (%)

• Laboratory
• Hospital
• Home Care
• Academic Institute

Global Viral Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Viral Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Viral Testing revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Viral Testing revenues share in global market, 2021 (%)
• Key companies Viral Testing sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Viral Testing sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Agilent Technologies
• Thermo Fisher Scientific
• QIAGEN International
• Lonza
• Wuxi Pharmatech (Cayman)
• Merck
• Eurofins Scientific
• General Electric
• Danaher
• Bio-Rad Laboratories
• BD
• Biospherix
• Novogene Corporation
• Sartorius